• Go to navigation
  • Go to content
AZ Brixham Laboratories

You are here

  • Home
  • Services to Industry
  • Biocidal Products
  • Implementation of the Directive

Astrazeneca global websites

  • AstraZeneca Websites

Main navigation

  • Home
  • News Archive
  • Introduction to Brixham Environmental Laboratory
  • Services to Industry
    • Industrial Chemicals (REACH)
    • Human Pharmaceuticals
    • Plant Protection
    • Veterinary Medicines
    • Biocidal Products
      • Testing requirements
      • Implementation of the Directive
      • Biocidal Product?
      • What is a Biocidal active?
  • Laboratory Capabilities
  • Innovative Environmental Science & Technologies
  • Useful Links
  • Free Resources
  • Find us
  • Contact
  • Download a brochure
  • Study Information Request
  • Sitemap
  • A-Z Index
  • REACH Seminar Presentations now available for viewing
  • REACH Testing Alliance
  • SETAC posters for downloading

Implementation of the Biocidal Products Directive for New Active Substances

Manufacturers of new active substances must produce a full dossier, including all test reports and the risk assessment to man and the environment. These data must be submitted to the Rapporteur Member State who, in cooperation with all other Member States, will decide if the active substance will be entered onto Annex 1 or not.

So far, this process has been started for biocidal active substances that have been notified for product type 08 (wood preservatives) and 14 (rodenticides).

If, following review, an active substance is included on Annex 1, then authorisation of individual products containing that active substance can occur. If inclusion in Annex 1 is not possible, then products containing that active substance can no longer be placed on the EU market.

  • Advanced search

Quick links

  • AstraZeneca International
  • REACH Testing Consortium
  • News from Chemical Watch
  • Contact Us for REACH Testing
  • What our customers have to say about us

Page tools

  • Print
  • Bookmark this page
AstraZeneca

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2009